Massive transfusion: new insights

Area of Science:

• Trauma Surgery
• Transfusion Medicine
• Emergency Medicine

Background:

• Massive transfusion (MT) remains critical for managing uncontrolled hemorrhage.
• Advances in resuscitation strategies are crucial for improving patient survival.
• Earlier hemorrhage control significantly impacts patient outcomes.

Purpose of the Study:

• To review recent advances in massive transfusion protocols.
• To highlight the shift towards hemostatic resuscitation and balanced blood product ratios.
• To discuss the role of early hemostasis assessment in guiding therapy.

Main Methods:

• Review of recent literature on massive transfusion protocols.
• Analysis of emerging resuscitation strategies like hypotensive resuscitation and hemostatic resuscitation.
• Examination of evidence supporting specific blood product ratios (e.g., 1:1:1 RBC:plasma:platelets).

Main Results:

• Increased use of plasma and platelets in MT to maintain coagulation.
• Advocacy for a 1:1:1 ratio of packed RBCs, fresh frozen plasma, and platelets to prevent coagulopathy.
• Reduced use of isotonic crystalloids in favor of hemostatic agents.
• Association of the 1:1:1 ratio with decreased mortality in trauma patients.

Conclusions:

• Modern MT protocols focus on early, balanced administration of blood products.
• Hemostatic resuscitation and standardized ratios are key to managing coagulopathy in trauma.
• Early assessment of hemostatic abnormalities guides targeted therapy and improves outcomes.